List of Tables
Table 1. Global Macromolecular Single-target Angiogenesis Inhibitor Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Macromolecular Single-target Angiogenesis Inhibitor Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Macromolecular Single-target Angiogenesis Inhibitor Market Competitive Situation by Manufacturers in 2025
Table 4. Global Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Macromolecular Single-target Angiogenesis Inhibitor Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Macromolecular Single-target Angiogenesis Inhibitor, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Macromolecular Single-target Angiogenesis Inhibitor, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Macromolecular Single-target Angiogenesis Inhibitor, Product Types and Applications
Table 12. Global Key Manufacturers of Macromolecular Single-target Angiogenesis Inhibitor, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Macromolecular Single-target Angiogenesis Inhibitor Companies by Tier (Tier 1, Tier 2, Tier 3), based on Macromolecular Single-target Angiogenesis Inhibitor Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Macromolecular Single-target Angiogenesis Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Macromolecular Single-target Angiogenesis Inhibitor Sales by Region (K Units), 2021–2026
Table 18. Global Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Region (2021–2026)
Table 19. Global Macromolecular Single-target Angiogenesis Inhibitor Sales by Region (K Units), 2027–2032
Table 20. Global Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Region (2027–2032)
Table 21. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 22. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Region (2021–2026)
Table 23. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 24. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Region (2027–2032)
Table 25. North America Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2021–2026
Table 27. North America Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2027–2032
Table 28. North America Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 29. North America Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2021–2026
Table 32. Europe Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2027–2032
Table 33. Europe Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Macromolecular Single-target Angiogenesis Inhibitor Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Macromolecular Single-target Angiogenesis Inhibitor Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Macromolecular Single-target Angiogenesis Inhibitor Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Macromolecular Single-target Angiogenesis Inhibitor Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Macromolecular Single-target Angiogenesis Inhibitor Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2021–2026
Table 42. Latin America Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2027–2032
Table 43. Latin America Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Macromolecular Single-target Angiogenesis Inhibitor Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Macromolecular Single-target Angiogenesis Inhibitor Revenue by Country (US$ Million), 2027–2032
Table 50. Global Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units) by Type (2021–2026)
Table 51. Global Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units) by Type (2027–2032)
Table 52. Global Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Type (2021–2026)
Table 53. Global Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Type (2027–2032)
Table 54. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Type (2021–2026)
Table 57. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Type (2027–2032)
Table 58. Global Macromolecular Single-target Angiogenesis Inhibitor Price (US$/Unit) by Type (2021–2026)
Table 59. Global Macromolecular Single-target Angiogenesis Inhibitor Price (US$/Unit) by Type (2027–2032)
Table 60. Global Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units) by Application (2021–2026)
Table 61. Global Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units) by Application (2027–2032)
Table 62. Global Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Application (2021–2026)
Table 63. Global Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Application (2027–2032)
Table 64. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Application (2021–2026)
Table 67. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Application (2027–2032)
Table 68. Global Macromolecular Single-target Angiogenesis Inhibitor Price (US$/Unit) by Application (2021–2026)
Table 69. Global Macromolecular Single-target Angiogenesis Inhibitor Price (US$/Unit) by Application (2027–2032)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Bayer Macromolecular Single-target Angiogenesis Inhibitor Product
Table 74. Bayer Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sanofi Macromolecular Single-target Angiogenesis Inhibitor Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Eli Lilly Company Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Eli Lilly Macromolecular Single-target Angiogenesis Inhibitor Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. Roche Company Information
Table 86. Roche Description and Business Overview
Table 87. Roche Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Roche Macromolecular Single-target Angiogenesis Inhibitor Product
Table 89. Roche Recent Developments/Updates
Table 90. Amneal Pharmaceuticals Company Information
Table 91. Amneal Pharmaceuticals Description and Business Overview
Table 92. Amneal Pharmaceuticals Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Amneal Pharmaceuticals Macromolecular Single-target Angiogenesis Inhibitor Product
Table 94. Amneal Pharmaceuticals Recent Developments/Updates
Table 95. Amgen Company Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Amgen Macromolecular Single-target Angiogenesis Inhibitor Product
Table 99. Amgen Recent Developments/Updates
Table 100. Celltrion Healthcare Company Information
Table 101. Celltrion Healthcare Description and Business Overview
Table 102. Celltrion Healthcare Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Celltrion Healthcare Macromolecular Single-target Angiogenesis Inhibitor Product
Table 104. Celltrion Healthcare Recent Developments/Updates
Table 105. Pfizer Company Information
Table 106. Pfizer Description and Business Overview
Table 107. Pfizer Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Pfizer Macromolecular Single-target Angiogenesis Inhibitor Product
Table 109. Pfizer Recent Developments/Updates
Table 110. Chia Tai Tianqing Company Information
Table 111. Chia Tai Tianqing Description and Business Overview
Table 112. Chia Tai Tianqing Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Chia Tai Tianqing Macromolecular Single-target Angiogenesis Inhibitor Product
Table 114. Chia Tai Tianqing Recent Developments/Updates
Table 115. Qilu Pharma Company Information
Table 116. Qilu Pharma Description and Business Overview
Table 117. Qilu Pharma Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Qilu Pharma Macromolecular Single-target Angiogenesis Inhibitor Product
Table 119. Qilu Pharma Recent Developments/Updates
Table 120. SinoCellTech Company Information
Table 121. SinoCellTech Description and Business Overview
Table 122. SinoCellTech Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. SinoCellTech Macromolecular Single-target Angiogenesis Inhibitor Product
Table 124. SinoCellTech Recent Developments/Updates
Table 125. Innovent Company Information
Table 126. Innovent Description and Business Overview
Table 127. Innovent Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Innovent Macromolecular Single-target Angiogenesis Inhibitor Product
Table 129. Innovent Recent Developments/Updates
Table 130. Jiangsu Hengrui Pharmaceuticals Company Information
Table 131. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 132. Jiangsu Hengrui Pharmaceuticals Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Jiangsu Hengrui Pharmaceuticals Macromolecular Single-target Angiogenesis Inhibitor Product
Table 134. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Macromolecular Single-target Angiogenesis Inhibitor Distributors List
Table 138. Macromolecular Single-target Angiogenesis Inhibitor Customers List
Table 139. Macromolecular Single-target Angiogenesis Inhibitor Market Trends
Table 140. Macromolecular Single-target Angiogenesis Inhibitor Market Drivers
Table 141. Macromolecular Single-target Angiogenesis Inhibitor Market Challenges
Table 142. Macromolecular Single-target Angiogenesis Inhibitor Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Macromolecular Single-target Angiogenesis Inhibitor
Figure 2. Global Macromolecular Single-target Angiogenesis Inhibitor Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Macromolecular Single-target Angiogenesis Inhibitor Market Share by Type: 2025 & 2032
Figure 4. Aflibercept Product Picture
Figure 5. Ramucirumab Product Picture
Figure 6. Bevacizumab Product Picture
Figure 7. Other Product Picture
Figure 8. Global Macromolecular Single-target Angiogenesis Inhibitor Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Macromolecular Single-target Angiogenesis Inhibitor Market Share by Application: 2025 & 2032
Figure 10. Degenerative Eye Diseases
Figure 11. Cancer
Figure 12. Other
Figure 13. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Macromolecular Single-target Angiogenesis Inhibitor Market Size (US$ Million), 2021–2032
Figure 15. Global Macromolecular Single-target Angiogenesis Inhibitor Sales (K Units), 2021–2032
Figure 16. Global Macromolecular Single-target Angiogenesis Inhibitor Average Price (US$/Unit), 2021–2032
Figure 17. Macromolecular Single-target Angiogenesis Inhibitor Report Years Considered
Figure 18. Macromolecular Single-target Angiogenesis Inhibitor Sales Share by Manufacturers in 2025
Figure 19. Global Macromolecular Single-target Angiogenesis Inhibitor Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Macromolecular Single-target Angiogenesis Inhibitor Players: Market Share by Revenue in Macromolecular Single-target Angiogenesis Inhibitor in 2025
Figure 21. Macromolecular Single-target Angiogenesis Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Macromolecular Single-target Angiogenesis Inhibitor Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Country (2021–2032)
Figure 24. North America Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Country (2021–2032)
Figure 25. United States Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Country (2021–2032)
Figure 28. Europe Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Country (2021–2032)
Figure 29. Germany Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Region (2021–2032)
Figure 36. China Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Country (2021–2032)
Figure 44. Latin America Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Macromolecular Single-target Angiogenesis Inhibitor Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Macromolecular Single-target Angiogenesis Inhibitor Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Macromolecular Single-target Angiogenesis Inhibitor Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Macromolecular Single-target Angiogenesis Inhibitor by Type (2021–2032)
Figure 55. Global Revenue Market Share of Macromolecular Single-target Angiogenesis Inhibitor by Type (2021–2032)
Figure 56. Global Macromolecular Single-target Angiogenesis Inhibitor Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Macromolecular Single-target Angiogenesis Inhibitor by Application (2021–2032)
Figure 58. Global Revenue Market Share of Macromolecular Single-target Angiogenesis Inhibitor by Application (2021–2032)
Figure 59. Global Macromolecular Single-target Angiogenesis Inhibitor Price (US$/Unit) by Application (2021–2032)
Figure 60. Macromolecular Single-target Angiogenesis Inhibitor Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
